Translational Cancer Research

Papers
(The H4-Index of Translational Cancer Research is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma78
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study69
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report42
Molecular basis of heterogeneity in small cell lung cancer36
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study28
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial27
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer24
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study24
Construction of molecular subtypes and prognostic model for breast cancer based on sulfur metabolism-related genes21
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors21
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?20
Identification of neuronal synapse-related signatures and potential therapeutic drugs in colorectal cancer based on machine learning algorithms and molecular docking20
Key considerations for interpreting patient-reported outcomes in deep inferior epigastric artery perforator flap reconstruction with post-mastectomy radiotherapy20
Unveiling prognostic factors and predictive modeling in lung adenocarcinoma with neuroendocrine differentiation20
Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma19
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma19
Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes19
Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study19
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis19
0.23125791549683